{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:31:18Z","timestamp":1769027478706,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016209","name":"Bilimsel Ara\u015ft\u0131rma Projeleri, Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","award":["TTU-2013-4566"],"award-info":[{"award-number":["TTU-2013-4566"]}],"id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02183-4","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T17:02:06Z","timestamp":1693414926000},"page":"645-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular evaluation and endothelial dysfunction in Cushing syndrome following remission: a prospective study"],"prefix":"10.1007","volume":"47","author":[{"given":"A.","family":"Hacioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. T.","family":"Firat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-2352","authenticated-orcid":false,"given":"Z.","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tanriverdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Selcuklu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Unluhizarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kelestimur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"issue":"4","key":"2183_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","volume":"40","author":"J Etxabe","year":"1994","unstructured":"Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40(4):479\u2013484. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02486.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2183_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","volume":"115","author":"JE Deanfield","year":"2007","unstructured":"Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285\u20131295. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.652859","journal-title":"Circulation"},{"issue":"2","key":"2183_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257\u2013265. https:\/\/doi.org\/10.1016\/s0735-1097(01)01746-6","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2183_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/ncpcardio1163","volume":"5","author":"E de Groot","year":"2008","unstructured":"de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML et al (2008) Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 5(5):280\u2013288. https:\/\/doi.org\/10.1038\/ncpcardio1163","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"2183_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","volume":"168","author":"RT Ras","year":"2013","unstructured":"Ras RT, Streppel MT, Draijer R, Zock PL (2013) Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol 168(1):344\u2013351. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.047","journal-title":"Int J Cardiol"},{"issue":"3","key":"2183_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1507\/endocrj.k09e-260","volume":"57","author":"I Akaza","year":"2010","unstructured":"Akaza I, Yoshimoto T, Tsuchiya K, Hirata Y (2010) Endothelial dysfunction aassociated with hypercortisolism is reversible in Cushing\u2019s syndrome. Endocr J 57(3):245\u2013252. https:\/\/doi.org\/10.1507\/endocrj.k09e-260","journal-title":"Endocr J"},{"issue":"3","key":"2183_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/07853890.2016.1252055","volume":"49","author":"R Lupoli","year":"2017","unstructured":"Lupoli R, Ambrosino P, Tortora A, Barba L, Lupoli GA, Di Minno MN (2017) Markers of atherosclerosis in patients with Cushing\u2019s syndrome: a meta-analysis of literature studies. Ann Med 49(3):206\u2013216. https:\/\/doi.org\/10.1080\/07853890.2016.1252055","journal-title":"Ann Med"},{"issue":"12","key":"2183_CR8","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/s0735-1097(03)00493-5","volume":"41","author":"ML Muiesan","year":"2003","unstructured":"Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M et al (2003) Left ventricular structural and functional characteristics in Cushing\u2019s syndrome. J Am Coll Cardiol 41(12):2275\u20132279. https:\/\/doi.org\/10.1016\/s0735-1097(03)00493-5","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2183_CR9","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1210\/jcem.84.8.5896","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M et al (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab 84(8):2664\u20132672. https:\/\/doi.org\/10.1210\/jcem.84.8.5896","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2183_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","volume":"76","author":"PM Toja","year":"2012","unstructured":"Toja PM, Branzi G, Ciambellotti F, Radaelli P, De Martin M, Lonati LM et al (2012) Clinical relevance of cardiac structure and function abnormalities in patients with Cushing\u2019s syndrome before and after cure. Clin Endocrinol (Oxf) 76(3):332\u2013338. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04206.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2183_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","volume":"33","author":"AM Isidori","year":"2015","unstructured":"Isidori AM, Graziadio C, Paragliola RM, Cozzolino A, Ambrogio AG, Colao A et al (2015) The hypertension of Cushing\u2019s syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J Hypertens 33(1):44\u201360. https:\/\/doi.org\/10.1097\/HJH.0000000000000415","journal-title":"J Hypertens"},{"issue":"6","key":"2183_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1530\/eje.0.1490549","volume":"149","author":"G Kirilov","year":"2003","unstructured":"Kirilov G, Tomova A, Dakovska L, Kumanov P, Shinkov A, Alexandrov AS (2003) Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing\u2019s syndrome. Eur J Endocrinol 149(6):549\u2013553. https:\/\/doi.org\/10.1530\/eje.0.1490549","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2183_CR13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4158\/EP15990.OR","volume":"22","author":"CG Ozsurekci","year":"2016","unstructured":"Ozsurekci CG, Akturk M, Ozkan C, Gulbahar O, Altinova AE, Yalcin M et al (2016) Asymmetric dimethylarginine levels and atherosclerosis markers in cushing syndrome. Endocr Pract 22(9):1088\u20131095. https:\/\/doi.org\/10.4158\/EP15990.OR","journal-title":"Endocr Pract"},{"issue":"1","key":"2183_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cen.13230","volume":"86","author":"N Shah","year":"2017","unstructured":"Shah N, Ruiz HH, Zafar U, Post KD, Buettner C, Geer EB (2017) Proinflammatory cytokines remain elevated despite long-term remission in Cushing\u2019s disease: a prospective study. Clin Endocrinol (Oxf) 86(1):68\u201374. https:\/\/doi.org\/10.1111\/cen.13230","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2183_CR15","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95(5):2409\u20132415. https:\/\/doi.org\/10.1172\/JCI117936","journal-title":"J Clin Invest"},{"issue":"3","key":"2183_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/a:1018758409934","volume":"9","author":"AD Simon","year":"2000","unstructured":"Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE (2000) Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis 9(3):217\u2013222. https:\/\/doi.org\/10.1023\/a:1018758409934","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"2183_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4158\/EP14399.OR","volume":"21","author":"K Shivaprasad","year":"2015","unstructured":"Shivaprasad K, Kumar M, Dutta D, Sinha B, Mondal SA, Maisnam I et al (2015) Increased soluble TNF receptor-1 and glutathione peroxidase may predict carotid intima media thickness in females with cushing syndrome. Endocr Pract 21(3):286\u2013295. https:\/\/doi.org\/10.4158\/EP14399.OR","journal-title":"Endocr Pract"},{"issue":"4","key":"2183_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2265.2007.02774.x","volume":"66","author":"E Setola","year":"2007","unstructured":"Setola E, Losa M, Lanzi R, Lucotti P, Monti LD, Castrignano T et al (2007) Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing\u2019s disease from metabolic syndrome. Clin Endocrinol (Oxf) 66(4):586\u2013592. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02774.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2183_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/1043-4666(92)90037-r","volume":"4","author":"GM Doherty","year":"1992","unstructured":"Doherty GM, Jensen JC, Buresh CM, Norton JA (1992) Hormonal regulation of inflammatory cell cytokine transcript and bioactivity production in response to endotoxin. Cytokine 4(1):55\u201362. https:\/\/doi.org\/10.1016\/1043-4666(92)90037-r","journal-title":"Cytokine"},{"issue":"6","key":"2183_CR20","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1210\/jcem.81.6.8964868","volume":"81","author":"DA Papanicolaou","year":"1996","unstructured":"Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP (1996) Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab 81(6):2303\u20132306. https:\/\/doi.org\/10.1210\/jcem.81.6.8964868","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2183_CR21","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM et al (2008) The diagnosis of cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2183_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiogr 32(1):1\u201364. https:\/\/doi.org\/10.1016\/j.echo.2018.06.004","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"2183_CR23","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","volume":"73","author":"P Muntner","year":"2019","unstructured":"Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S et al (2019) Measurement of blood pressure in humans: a scientific statement from the american heart association. Hypertension 73(5):e35\u2013e66. https:\/\/doi.org\/10.1161\/HYP.0000000000000087","journal-title":"Hypertension"},{"issue":"6","key":"2183_CR24","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1210\/jc.2002-021558","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C et al (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88(6):2527\u20132533. https:\/\/doi.org\/10.1210\/jc.2002-021558","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2183_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12020-018-1819-6","volume":"64","author":"MH Schernthaner-Reiter","year":"2019","unstructured":"Schernthaner-Reiter MH, Siess C, Gessl A, Scheuba C, Wolfsberger S, Riss P et al (2019) Factors predicting long-term comorbidities in patients with Cushing\u2019s syndrome in remission. Endocrine 64(1):157\u2013168. https:\/\/doi.org\/10.1007\/s12020-018-1819-6","journal-title":"Endocrine"},{"issue":"7","key":"2183_CR26","first-page":"509","volume":"8","author":"F Fallo","year":"1994","unstructured":"Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M (1994) Left ventricular structural characteristics in Cushing\u2019s syndrome. J Hum Hypertens 8(7):509\u2013513 (Epub 1994\/07\/01 PubMed PMID: 7932514)","journal-title":"J Hum Hypertens"},{"issue":"4","key":"2183_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 29(4):277\u2013314. https:\/\/doi.org\/10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"2183_CR28","doi-asserted-by":"publisher","first-page":"569914","DOI":"10.3389\/fphar.2020.569914","volume":"11","author":"A Cziraki","year":"2020","unstructured":"Cziraki A, Lenkey Z, Sulyok E, Szokodi I, Koller A (2020) L-Arginine-nitric oxide-asymmetric dimethylarginine pathway and the coronary circulation: translation of basic science results to clinical practice. Front Pharmacol 11:569914. https:\/\/doi.org\/10.3389\/fphar.2020.569914","journal-title":"Front Pharmacol"},{"issue":"1","key":"2183_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0656-x","volume":"17","author":"D Tsikas","year":"2018","unstructured":"Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA (2018) Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Cardiovasc Diabetol 17(1):1. https:\/\/doi.org\/10.1186\/s12933-017-0656-x","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2183_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.arr.2012.02.003","volume":"12","author":"Y Bai","year":"2013","unstructured":"Bai Y, Sun L, Du L, Zhang T, Xin W, Lan X et al (2013) Association of circulating levels of asymmetric dimethylarginine (ADMA) with carotid intima-media thickness: evidence from 6168 participants. Ageing Res Rev 12(2):699\u2013707. https:\/\/doi.org\/10.1016\/j.arr.2012.02.003","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2183_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.18388\/abp.2020_5424","volume":"68","author":"Z Fiodorenko-Dumas","year":"2021","unstructured":"Fiodorenko-Dumas Z, Dumas I, Rabczynski M, Malecki R, Adamiec R, Paprocka-Borowicz M (2021) Lack of evidence of the correlation between plasma Asymmetrical Dimethylarginine correlation and IMT in type 2 diabetic patients with chronic vascular complication. Acta Biochim Pol 68(1):143\u2013149. https:\/\/doi.org\/10.18388\/abp.2020_5424","journal-title":"Acta Biochim Pol"},{"issue":"8","key":"2183_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/00004872-199816080-00001","volume":"16","author":"WG Haynes","year":"1998","unstructured":"Haynes WG, Webb DJ (1998) Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 16(8):1081\u20131098. https:\/\/doi.org\/10.1097\/00004872-199816080-00001","journal-title":"J Hypertens"},{"issue":"4 Suppl 2","key":"2183_CR33","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/00005344-200000002-00007","volume":"35","author":"J Goddard","year":"2000","unstructured":"Goddard J, Webb DJ (2000) Plasma endothelin concentrations in hypertension. J Cardiovasc Pharmacol 35(4 Suppl 2):S25-31. https:\/\/doi.org\/10.1097\/00005344-200000002-00007","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"2183_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/cs0780261","volume":"78","author":"AP Davenport","year":"1990","unstructured":"Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C et al (1990) A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci (Lond) 78(3):261\u2013264. https:\/\/doi.org\/10.1042\/cs0780261","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2183_CR35","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/jc.2002-021030","volume":"88","author":"T Ueland","year":"2003","unstructured":"Ueland T, Kristo C, Godang K, Aukrust P, Bollerslev J (2003) Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing\u2019s syndrome: a longitudinal study. J Clin Endocrinol Metab 88(4):1492\u20131496. https:\/\/doi.org\/10.1210\/jc.2002-021030","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2183_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000362724","volume":"22","author":"D Cruz-Topete","year":"2015","unstructured":"Cruz-Topete D, Cidlowski JA (2015) One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. NeuroImmunoModulation 22(1\u20132):20\u201332. https:\/\/doi.org\/10.1159\/000362724","journal-title":"NeuroImmunoModulation"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02183-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02183-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02183-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T17:28:36Z","timestamp":1709227716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02183-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02183-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"19 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the ethics committee of Erciyes University Medical School (2013\/155). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}